Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 Jul;36(7):1400–1403. doi: 10.1128/aac.36.7.1400

Pharmacokinetics of imipenem in serum and skin window fluid in healthy adults after intramuscular or intravenous administration.

S A Signs 1, J S Tan 1, S J Salstrom 1, T M File 1
PMCID: PMC191593  PMID: 1510434

Abstract

The pharmacokinetic profiles of imipenem after intramuscular (i.m.) and intravenous injections were examined in adult volunteers. Levels of imipenem in serum after i.m. injection of a microcrystalline suspension of imipenem-cilastatin (500 mg each) reached a peak (8.0 micrograms/ml) at 1.5 h after administration, and concentrations were maintained in excess of 1.5 micrograms/ml for 6 h. Serum elimination half-life (1.3 h), volume of distribution (14.5 liters), and area under the curve (AUC; 27.8 micrograms.h/ml) after i.m. injection did not significantly differ from those of a comparable dose given by intravenous infusion. Bioavailability after i.m. injection was 89%. Imipenem levels in skin window fluid after i.m. administration were maximal (4.3 micrograms/ml) at 4 h after injection, at which time imipenem concentrations exceeded those produced by intravenous infusion. The AUCskin window/AUCserum ratio for skin window fluid after i.m. injection was 68%, indicating good penetration of the drug into skin fluid. This study shows that i.m. injection of 500 mg of imipenem-cilastatin results in concentrations of imipenem in serum and skin fluid that are, for at least 6 h, consistent with antimicrobial activity against susceptible organisms.

Full text

PDF
1400

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett J. V., Brodie J. L., Benner E. J., Kirby W. M. Simplified, accurate method for antibiotic assay of clinical specimens. Appl Microbiol. 1966 Mar;14(2):170–177. doi: 10.1128/am.14.2.170-177.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bustamante C. I., Drusano G. L., Tatem B. A., Standiford H. C. Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1984 Nov;26(5):678–682. doi: 10.1128/aac.26.5.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Drusano G. L., Standiford H. C., Bustamante C., Forrest A., Rivera G., Leslie J., Tatem B., Delaportas D., MacGregor R. R., Schimpff S. C. Multiple-dose pharmacokinetics of imipenem-cilastatin. Antimicrob Agents Chemother. 1984 Nov;26(5):715–721. doi: 10.1128/aac.26.5.715. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Drusano G. L., Standiford H. C. Pharmacokinetic profile of imipenem/cilastatin in normal volunteers. Am J Med. 1985 Jun 7;78(6A):47–53. doi: 10.1016/0002-9343(85)90101-9. [DOI] [PubMed] [Google Scholar]
  5. Garau J., Calandra G. B. Intramuscular imipenem/cilastatin in multiple-dose treatment regimens: review of the worldwide clinical experience. Chemotherapy. 1991;37 (Suppl 2):44–52. doi: 10.1159/000238919. [DOI] [PubMed] [Google Scholar]
  6. Kahan F. M., Rogers J. D. Imipenem/cilastatin: evolution of the sustained-release intramuscular formulation. Chemotherapy. 1991;37 (Suppl 2):21–25. doi: 10.1159/000238915. [DOI] [PubMed] [Google Scholar]
  7. Renneberg J., Walder M. Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo. Antimicrob Agents Chemother. 1989 Oct;33(10):1714–1720. doi: 10.1128/aac.33.10.1714. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Sexton D. J., Wlodaver C. G., Tobey L. E., Yangco B. G., Graziani A. L., MacGregor R. R. Twice daily intramuscular imipenem/cilastatin in the treatment of skin and soft tissue infections. Chemotherapy. 1991;37 (Suppl 2):26–30. doi: 10.1159/000238916. [DOI] [PubMed] [Google Scholar]
  9. Tan J. S., Trott A., Phair J. P., Watanakunakorn C. A method for measurement of antibiotics in human interstitial fluid. J Infect Dis. 1972 Nov;126(5):492–497. doi: 10.1093/infdis/126.5.492. [DOI] [PubMed] [Google Scholar]
  10. Wise R., Donovan I. A., Lockley M. R., Drumm J., Andrews J. M. The pharmacokinetics and tissue penetration of imipenem. J Antimicrob Chemother. 1986 Dec;18 (Suppl E):93–101. doi: 10.1093/jac/18.supplement_e.93. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES